Medidata Patient Experience

51. Medidata Decentralized Clinical Trials (DCT) Program 1/2/2023

    The Medidata DCT Program is a unique, innovative, and powerful technology solution to virtualize your entire clinical trial, including patient participation, data monitoring and oversight activities, and patient drug dispensation and supply management.

52. Medidata Decentralized Clinical Trials Program 11/16/2022

    Watch this brief video to see how the industry’s only scalable, end-to-end offering for decentralized clinical trials can connect trial experiences for patients, sites and sponsors.

53. Site Perspectives On Decentralized Clinical Trials 11/15/2022

    Discover why understanding clinical research sites’ experiences and perspectives on DCTs will help industry stakeholders  refine trial design, operational procedures, and regulatory policy to better serve patients and sites.

54. Hassle-Free Imaging In Clinical Trials 6/14/2022

    In this paper, writers ask readers to consider how far the field of imaging has transpired in recent times, as well as explore the latest innovations, and contemplate what possibilities lie ahead.

55. A Leading Academic Medical Center Monitors Newly Diagnosed Myeloma Patients 5/20/2022

    Learn how eCOA helped to motivate patients and increased engagement around experiences outside of the clinical setting, which otherwise may have gone unmentioned.

56. DCTs: What Are They And What Are The Direct Impacts To DMs? 1/21/2022

    In 2020, the need for alternative approaches to clinical trial execution and data capture became a reality overnight. The concept of implementing components of decentralization within a clinical trial became one of ‘here and now,’ versus a concept of the future. 

57. Medidata eConsent – Empowering Patients Right From The Start 8/2/2021

    Medidata’s eConsent is an innovative, patient-friendly, electronic informed consent and patient enrollment system for clinical trials. Through the use of multimedia technology, your patients are educated and guided through understanding key elements of a clinical trial.

58. Advancing DCTs Through A Unified Approach To eCOA And DHTs 7/6/2021

    Digital health technologies and assessments of patient-reported outcomes are on the rise. Read how uniting the two can better inform how patients experience their disease and respond to treatment.

59. Developing A Mobile Sensor Strategy Journey For Better Study Outcomes 4/15/2021

    With the growth of digital health technologies and an increasingly large selection of possible devices, this white paper highlights considerations as sponsors and CROs develop their DHT strategy.

60. The Growth Of Phase IV Trials And The Need To Demonstrate Effectiveness Using Electronic Patient Reported Outcomes 7/10/2020

    This paper addresses and describes the growing need to satisfy the value perception of multiple stakeholders and the importance of Late Phase trials capturing Clinical Outcome Assessments (COA) and electronic Patient Reported Outcomes (ePRO) in relation to this.